Neutral
Dr. Reddy's Laboratories is receiving a "Hold" rating from MarketsMojo, reflecting cautious investor sentiment due to mixed FY26 results and subdued s...
Bullish
Dr. Reddy's Laboratories Limited announced full compliance with SEBI regulations for the financial year ended March 31, 2026, following an audit by M/...
Neutral
Dr. Reddy's Laboratories Ltd announced the transfer of unclaimed dividends and shares to the Investor Education and Protection Fund (IEPF) as per Sect...
Dr Reddy's Laboratories Ltd has released its earnings summary for the quarter that ended on March 31. The report provides key financial results for th...